tiprankstipranks
Advertisement
Advertisement

MPLT Stock Latest News

MapLight Therapeutics completes enrollment in ZEPHYR trial
The FlyMapLight Therapeutics completes enrollment in ZEPHYR trial
8h ago
MPLT
MapLight Therapeutics Announces Board Refresh and New Nominees
PremiumCompany Announcements
MapLight Therapeutics Announces Board Refresh and New Nominees
2d ago
8K
MPLT
MapLight Therapeutics initiated with a Buy at Needham
PremiumThe Fly
MapLight Therapeutics initiated with a Buy at Needham
23d ago
MPLT
Buy Rating on MapLight: Differentiated CNS Pipeline and Undervalued Schizophrenia Opportunity with Upside in Alzheimer’s and Neuropsychiatric Indications
PremiumRatings
Buy Rating on MapLight: Differentiated CNS Pipeline and Undervalued Schizophrenia Opportunity with Upside in Alzheimer’s and Neuropsychiatric Indications
24d ago
MPLT
MapLight Therapeutics initiated with a Buy at TD Cowen
PremiumThe Fly
MapLight Therapeutics initiated with a Buy at TD Cowen
24d ago
MPLT
MapLight Therapeutics Highlights Growing CNS Pipeline, Strong Cash Position
PremiumCompany AnnouncementsMapLight Therapeutics Highlights Growing CNS Pipeline, Strong Cash Position
1M ago
8K
MPLT
Canaccord starts MapLight with Buy into schizophrenia data
Premium
The Fly
Canaccord starts MapLight with Buy into schizophrenia data
1M ago
MPLT
MapLight Therapeutics initiated with a Buy at Canaccord
Premium
The Fly
MapLight Therapeutics initiated with a Buy at Canaccord
1M ago
MPLT
MapLight updates trial timelines and highlights CNS pipeline
PremiumCompany Announcements
MapLight updates trial timelines and highlights CNS pipeline
4M ago
8K
MPLT
MapLight Therapeutics expects topline results from ZEPHYR trial in Q3
PremiumThe Fly
MapLight Therapeutics expects topline results from ZEPHYR trial in Q3
4M ago
MPLT
MapLight Therapeutics receives fast track designation for ML-007C-MA for ADP
PremiumThe Fly
MapLight Therapeutics receives fast track designation for ML-007C-MA for ADP
4M ago
MPLT
MapLight’s Phase 2 Alzheimer’s Psychosis Trial Marks a Key Milestone for MPLT Investors
PremiumCompany Announcements
MapLight’s Phase 2 Alzheimer’s Psychosis Trial Marks a Key Milestone for MPLT Investors
4M ago
MPLT
MapLight’s ML-004 Autism Extension Study: What Ongoing Safety Data Mean for Investors
PremiumCompany AnnouncementsMapLight’s ML-004 Autism Extension Study: What Ongoing Safety Data Mean for Investors
4M ago
MPLT
MapLight Therapeutics, SandboxAQ announce strategic collaboration
Premium
The Fly
MapLight Therapeutics, SandboxAQ announce strategic collaboration
5M ago
MPLT
MapLight Therapeutics Advances CNS Drug Pipeline
Premium
Company Announcements
MapLight Therapeutics Advances CNS Drug Pipeline
5M ago
MPLT
MapLight Therapeutics Completes IPO and Raises $296.5M
PremiumCompany Announcements
MapLight Therapeutics Completes IPO and Raises $296.5M
5M ago
8K
MPLT
MapLight Therapeutics reports Q3 EPS ($37.18) vs ($25.08) last year
PremiumThe Fly
MapLight Therapeutics reports Q3 EPS ($37.18) vs ($25.08) last year
5M ago
MPLT
Positive Outlook on MapLight Therapeutics Amid ADEPT-2 Study Continuation and Upcoming Catalysts
PremiumRatings
Positive Outlook on MapLight Therapeutics Amid ADEPT-2 Study Continuation and Upcoming Catalysts
5M ago
MPLT
ADEPT-2 news ‘at face is a win’ for MapLight Therapeutics, says Stifel
PremiumThe Fly
ADEPT-2 news ‘at face is a win’ for MapLight Therapeutics, says Stifel
5M ago
BMY
MPLT
MapLight Therapeutics initiated with an Outperform at Leerink
PremiumThe FlyMapLight Therapeutics initiated with an Outperform at Leerink
5M ago
MPLT
Promising Investment in MapLight Therapeutics: Buy Rating Backed by Strategic Positioning and Strong Financials
Premium
Ratings
Promising Investment in MapLight Therapeutics: Buy Rating Backed by Strategic Positioning and Strong Financials
5M ago
MPLT
Buy Recommendation for MapLight Therapeutics: Promising Pipeline and Market Potential
Premium
Ratings
Buy Recommendation for MapLight Therapeutics: Promising Pipeline and Market Potential
5M ago
MPLT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >